Metal-Based Therapeutic Approaches for Overcoming Cancer Drug Resistance: Mechanisms, Drug Delivery Strategies, and Clinical Perspectives
Kirill V. Chernov, Artemii M. Savin, Daria E. Otvodnikova, Oleg A. Kuchur, Sergey A. Tsymbal · 2026
Read Metal-Based Therapeutic Approaches for Overcoming Cancer Drug Resistance: Mechanisms, Drug Delivery Strategies, and Clinical Perspectives by Kirill V. Chernov, Artemii M. Savin, Daria E. Otvodnikova, Oleg A. Kuchur, Sergey A. Tsymbal (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13220081.txt.
Description
Kirill V. Chernov and colleagues argue metal drugs are an underused answer to cancer drug resistance in a 2026 review. Resistance causes most relapses, targeted therapies are narrow, and chemotherapy is hard on patients. The authors contend that the next generation of agents must combine precision with versatility, and metal compounds do both.
Metals and their complexes act on cancer cells through routes foreign to organic drugs. They can kill without the standard apoptosis pathway, disrupt critical signaling, and be aimed with unusual precision, while their chemistry suits them to imaging and targeted delivery. The review travels from the role of metals in causing cancer through therapeutic, diagnostic, and delivery strategies built on them. The puzzle the authors keep returning to is translational: despite the advantages, few metal-based drugs have won approval. They close by examining what blocks development, from evaluation to formulation, and where the field's best chances lie.
Catalog record
| CREATOR | Kirill V. Chernov, Artemii M. Savin, Daria E. Otvodnikova, Oleg A. Kuchur, Sergey A. Tsymbal |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 99 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |